Close Menu

stock split

NEW YORK (GenomeWeb) – WaferGen Biosystems said after the close of the market on Monday that it has effected a one-for-10 reverse stock split as it seeks to list its shares on the Nasdaq Capital Market.

NEW YORK (GenomeWeb News) — Transgenomic said today that it has filed an application to list its common shares on the Nasdaq Capital Market, and that it will initiate a 1-for-12 reverse stock split.

NEW YORK (GenomeWeb News) – Wafergen Biosystems announced late on Tuesday a series of moves — including a stock split, a capital restructuring, and a private placement to raise up to roughly $17.3 million — to boost its share price and improve its cash position.

NEW YORK (GenomeWeb News) – PositiveID said today its board has approved a 1-for-25 reverse stock split, commencing at the start of trading on April 23.

NEW YORK (GenomeWeb News) – CombiMatrix announced after the close of the market on Tuesday that shareholders approved the second tranche of a private placement that seeks to raise $2.5 million in total.

NEW YORK (GenomeWeb News) – Trovagene announced late on Tuesday the pricing of a public offering of 1.15 million units and said that its shares will begin trading on the Nasdaq Capital Market today under ticker symbol "TROV".

NEW YORK (GenomeWeb News) – Rosetta Genomics today said that its shareholders have approved a one-for-fifteen reverse stock split, which will take effect before trading opens Tuesday.

NEW YORK (GenomeWeb News) – GeneNews announced after the close of the market last night that its shareholders have approved the company's plan for a share consolidation, as well as the extension to the term of certain share purchase warrants.

The move will enable the company to meet the Nasdaq's $1 minimum bid price requirement.

The company is doing the reverse split to meet a minimum listing requirement of $1 per share.

Pages

A study of families explores how children transmit SARS-CoV-2, according to the Associated Press.

US Agricultural Research Service scientists have sequenced the genome of the Asian giant hornet.

According to the Economist, pooled testing for COVID-19 could help alleviate strains on testing labs.

In Science this week: MIT researchers outline approach dubbed translatable components regression to predict treatment response among IBD patients.